Omega Fund Management, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001637359

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 10 positions · Total reported value $125.16M · Top-10 concentration 100.0% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.5% · 1 new · 4 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.0% · vs SPY -26.1% · Prev Value $185.69M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -24.7% · vs SPY -26.8% · Latest Value $125.16M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Omega Fund Management, LLC disclosed 10 equity positions with a combined reported value of $125.16M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were NUVB ($40.05M), BCAX ($32.75M), BBNX ($18.26M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, Omega Fund Management, LLC opened 1 new positions, trimmed 4 and fully exited 1, a turnover rate of 54.5% of positions. The portfolio's overlap with the prior quarter was 82% of names.

The largest new positions opened in Q3 2026 were IMUX ($4.00M).

Of the 1 positions fully exited versus the prior quarter, the largest were ALMS ($6.79M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • IMUX IMMUNIC INC · $4.00M

Fully Exited (vs previous quarter)

  • ALMS ALUMIS INC · prev qtr: $6.79M

Insider Transactions (Form 4)

Latest Omega Fund Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Omega Fund Management, LLC, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 10 positions worth $125.16M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-74224 (status: Approved), registered 2012-03-30
  • Regulatory AUM (Form ADV): $1.71B as of 2026-03-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds
  • Website: omegafunds.com

Portfolio Structure

  • 10 positions · $125.16M reported value (Q3 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: NUVB (NUVATION BIO INC) at 32.0%
  • Average position size: $12.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 1 new, 4 reduced, 1 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund reduced exposure to most top holdings (6/10) but increased weights for 3 via price appreciation, suggesting a cautious stance on biotech/healthcare names despite sector-wide price gains. 2. Key moves: - Reduced: NUVB (shares -11.5%), BCAX (-3.4%), BBNX (-26.9%), KMTS (-64.5%) - New: IMUX (added, 3.20% weight) - No adds (only 1 new position, no explicit "Add" actions). 3. Portfolio structure: Active, concentrated (top 10 = 98.8%), heavily biased toward Health Care (100%), with high risk appetite (volatile biotech stocks, significant share reductions). 4. Per-holding one-liner: - NUVB: Nuvation Bio (biotech, unverified) - BCAX: Bicara Therapeutics (biotech, unverified) - BBNX: Beta Bionics (medical devices, unverified) - BBOT: BridgeBio Oncology (biotech, unverified) - KMTS: Kestra Med Technologies (medical tech, unverified) - IMUX: Immunex (biotech, unverified) - SANA: Sana Biotechnology (biotech, unverified) - IMA: Imagen Bio (biotech, unverified) - ENGN: EnGene Therapeutics (biotech, unverified) - ODTX: Odyssey Therapeutics (biotech, unverified) 5. Style summary: Aggressive biotech fund trimming losers while letting winners run, adding one new name.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 06:04

Sector Allocation

Health Care 100.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 7.15M $40.05M 32.00%
32.00%
Reduce
2 1.76M $32.75M 26.17%
26.17%
Reduce
3 962.01K $18.26M 14.59%
14.59%
Reduce
4 3.29M $13.49M 10.78%
10.78%
Hold
5 362.39K $10.25M 8.19%
8.19%
Reduce
6 430.18K $4.00M 3.20%
3.20%
New
7 843.75K $2.46M 1.97%
1.97%
Hold
8 455.36K $2.09M 1.67%
1.67%
Hold
9 876.36K $1.75M 1.40%
1.40%
Hold
10 2.89K $64.28K 0.05%
0.05%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 90% R 90% F1 90% (modelled on 2026-Q2; 9/10 hit)

Historical Backtest (11 quarters)

Avg precision 86% · recall 86% · F1 86% · avg rank error 1.7 · Top-10 turnover 15%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% LXEO · REPL · NUVB · ENGN · MORF · SPRB · KRON · IKNA · SANA · THRX NUVB · LXEO · REPL · ENGN · SANA · MORF · IKNA · IMUX · ENGNW · SYRS
2024-Q2 90% 90% 90% NUVB · LXEO · REPL · ENGN · SANA · MORF · IKNA · IMUX · ENGNW · SYRS NUVB · LXEO · REPL · ENGN · ALMS · MORF · SANA · IKNA · IMUX · SYRS
2024-Q3 80% 80% 80% NUVB · LXEO · REPL · ENGN · ALMS · MORF · SANA · IKNA · IMUX · SYRS BCAX · NUVB · REPL · LXEO · ENGN · ALMS · IKNA · SANA · IMUX · ENGNW
2024-Q4 90% 90% 90% BCAX · NUVB · REPL · LXEO · ENGN · ALMS · IKNA · SANA · IMUX · ENGNW BCAX · NUVB · UPB · REPL · LXEO · ALMS · IKNA · ENGN · IMUX · SANA
2025-Q1 80% 80% 80% BCAX · NUVB · UPB · REPL · LXEO · ALMS · IKNA · ENGN · IMUX · SANA KMTS · BCAX · BBNX · NUVB · REPL · UPB · LXEO · ALMS · IKNA · ENGN
2025-Q2 90% 90% 90% KMTS · BCAX · BBNX · NUVB · REPL · UPB · ALMS · LXEO · IKNA · ENGN BBNX · KMTS · UPB · NUVB · BCAX · REPL · LXEO · IKNA · SANA · ALMS
2025-Q3 70% 70% 70% BBNX · KMTS · UPB · NUVB · BCAX · REPL · LXEO · IKNA · SANA · ALMS KMTS · BBNX · BBOT · BCAX · NUVB · UPB · IMA · ENGN · SANA · ALMS
2025-Q4 100% 100% 100% KMTS · BBOT · BBNX · BCAX · NUVB · UPB · IMA · ENGN · SANA · ALMS NUVB · BBOT · BBNX · BCAX · KMTS · UPB · ENGN · ALMS · SANA · IMA
2026-Q1 90% 90% 90% NUVB · BBOT · BBNX · BCAX · KMTS · UPB · ENGN · ALMS · SANA · IMA BCAX · NUVB · BBOT · KMTS · BBNX · ENGN · ALMS · SANA · IMA · REPL
2026-Q2 90% 90% 90% BCAX · NUVB · BBOT · KMTS · BBNX · ENGN · ALMS · SANA · IMA · REPL BCAX · NUVB · KMTS · BBOT · BBNX · ALMS · SANA · IMA · ENGN · ODTX
2026-Q3 ★ 90% 90% 90% BCAX · NUVB · KMTS · BBOT · BBNX · ALMS · SANA · IMA · ENGN · ODTX NUVB · BCAX · BBNX · BBOT · KMTS · IMUX · SANA · IMA · ENGN · ODTX

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings1 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return-12.87%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+4.14%vs benchmark
Barra annualised vol84.5%Model estimate
Realised vol75.3%Annualised in window
Weighted beta1.49Raw exposure
Factor / specific risk32% / 68%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)75.282.790.297.7105.210-0110-2311-16Omega Fund Management, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-12.87%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+4.14%Portfolio − benchmark
Arithmetic return sum-10.04%Difference vs compounded is the cross term
Weighted raw beta1.49Weighted holding betas
Realised volatility (annualised)75.35%Daily returns in window
Barra model volatility (annualised)84.50%Factor + specific
Factor share of variance31.8%Barra factors
Specific share of variance68.2%Stock residuals
Reported value$64,28213F long US equity

2. Return attribution

The -10.04% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +0.33% 3.3%
Momentum & Growth 3 -0.51% -5.1%
Volatility & Tail Risk 7 -26.99% -268.7%
Industry 12 +6.98% 69.5%
Specific 1 +10.14% 101.0%
Return attribution (style + industry, %)-29.6-14.8+0.0+14.8+29.6Short-term Reversal+0.73Amihud Illiquidity-1.23Skewness+1.49Momentum-1.52Leverage (Downside Vol)-1.58Max Drawdown-1.73Beta+2.87Non-linear Size+3.10Size+3.23Residual Volatility+4.48Kurtosis-5.14Mid Cap-5.17Health Care+6.98Historical Volatility-27.38
Factor Type Exposure Factor return Contribution Share of |return|
Specific Specific — — +10.14% 101.0%
Health Care Industry +1.00 +6.98% +6.98% 69.5%
Residual Volatility Style +1.36 +3.29% +4.48% 44.6%
Size Style -1.66 -1.95% +3.23% 32.2%
Non-linear Size Style +3.07 +1.01% +3.10% 30.9%
Beta Style +0.65 +4.44% +2.87% 28.6%
Skewness Style -0.34 -4.39% +1.49% 14.8%
Short-term Reversal Style +0.84 +0.87% +0.73% 7.3%
Liquidity Style +1.04 +0.36% +0.37% 3.7%
Growth Style +0.16 +1.75% +0.28% 2.8%
Amihud Illiquidity Style +2.75 -0.45% -1.23% -12.2%
Momentum Style +0.38 -4.00% -1.52% -15.2%
Leverage (Downside Vol) Style +0.92 -1.71% -1.58% -15.7%
Max Drawdown Style +0.98 -1.76% -1.73% -17.2%
Kurtosis Style -0.68 +7.51% -5.14% -51.2%
Mid Cap Style +2.67 -1.94% -5.17% -51.5%
Historical Volatility Style +1.96 -14.00% -27.38% -272.7%

3. Risk attribution

Annualised volatility is 84.50%; factor risk explains 31.8% of variance and specific risk 68.2%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-73.6-36.8+0.0+36.8+73.6Growth+0.36Liquidity+0.72Size+0.99Kurtosis+1.05Short-term Reversal+1.13Leverage (Downside Vol)+1.50Beta+2.13Non-linear Size+2.20Residual Volatility+2.36Max Drawdown+2.51Health Care+3.76Mid Cap+3.92Historical Volatility+9.58Specific+68.15
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 68.2% +57.59% 57.6%
Historical Volatility Style +1.96 9.6% +8.09% 8.1%
Mid Cap Style +2.67 3.9% +3.31% 3.3%
Health Care Industry +1.00 3.8% +3.18% 3.2%
Max Drawdown Style +0.98 2.5% +2.12% 2.1%
Residual Volatility Style +1.36 2.4% +1.99% 2.0%
Non-linear Size Style +3.07 2.2% +1.86% 1.9%
Beta Style +0.65 2.1% +1.80% 1.8%
Leverage (Downside Vol) Style +0.92 1.5% +1.27% 1.3%
Short-term Reversal Style +0.84 1.1% +0.96% 1.0%
Kurtosis Style -0.68 1.1% +0.89% 0.9%
Size Style -1.66 1.0% +0.84% 0.8%
Liquidity Style +1.04 0.7% +0.61% 0.6%
Growth Style +0.16 0.4% +0.30% 0.3%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-2.1-0.70.72.13.5Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.66 +2.10 -3.76
Non-linear Size +3.07 +1.68 +1.39
Mid Cap +2.67 +0.13 +2.54
Beta +0.65 +1.29 -0.65
Momentum +0.38 +0.72 -0.34
Short-term Reversal +0.84 -0.64 +1.48
Residual Volatility +1.36 -0.40 +1.76
Historical Volatility +1.96 +0.86 +1.10
Liquidity +1.04 +0.11 +0.93
Amihud Illiquidity +2.75 +1.16 +1.60
Turnover -0.01 +0.21 -0.21
Growth +0.16 +0.58 -0.42
Leverage (Downside Vol) +0.92 +0.14 +0.78
Skewness -0.34 +0.24 -0.58
Kurtosis -0.69 +0.21 -0.90
Max Drawdown +0.98 -0.08 +1.06

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 0.0% 11.1% +0.00% +4.36% -2.39% -0.48% +0.48% -0.48%
Health Care 100.0% 1.7% -12.87% +8.29% +24.98% -0.37% -20.79% -13.01%
Total +23.98% +15.48% -36.63% +2.83%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
ODTX ODYSSEY THERAPEUTICS INC Health Care 100.00% -12.87% -12.87% Hold
Contribution rank Symbol Sector Weight Return Contribution
1 ODTX Health Care 100.00% -12.87% -12.87%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -12.87%, versus -17.01% for the QQQ synthetic benchmark — an excess of +4.14%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +6.98%, Residual Volatility +4.48%, Size +3.23%; the largest drags came from Historical Volatility -27.38%, Mid Cap -5.17%, Kurtosis -5.14%. Specific (stock-level) return contributed +10.14%.
  3. Risk attribution: Barra model volatility is 84.50% annualised; factor risk explains 32% of variance and specific risk 68%. The largest factor risk sources are Historical Volatility 9.6%, Mid Cap 3.9%, Health Care 3.8%.
  4. Style tilt: size -1.66, momentum +0.38, volatility +1.96, liquidity +1.04; the weighted raw beta is 1.49. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +23.98%, selection +15.48% and interaction -36.63%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Omega Fund Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Omega Fund Management, LLC reported 10 equity positions worth $125.16M in aggregate; its largest disclosed positions were NUVB ($40.05M), BCAX ($32.75M), BBNX ($18.26M).

How large is Omega Fund Management, LLC's portfolio?

Omega Fund Management, LLC reported $125.16M of long equity holdings across 10 positions as of 2026-Q3. Top-10 holdings account for 100.0% of reported value.

What is Omega Fund Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/omega-fund-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →